O Paradigma da Cessação Tabágica na Doença Mental Grave: Um Olhar Crítico
DOI:
https://doi.org/10.51338/rppsm.281Resumo
.
Downloads
Referências
Knowles S, Planner C, Bradshaw T, Peckham E, Man MS, Gilbody S. Making the journey with me: a qualitative study of experiences of a bespoke mental health smoking cessation intervention for service users with serious mental illness. BMC Psychiatry. 2016;16:193. Published 2016 Jun 8. doi:10.1186/s12888-016-0901-y. DOI: https://doi.org/10.1186/s12888-016-0901-y
Jackson JG, Diaz FJ, Lopez L, de Leon J. A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. Bipolar Disord. 2015;17(6):575-597. doi:10.1111/bdi.12319. DOI: https://doi.org/10.1111/bdi.12319
Dixon L, Medoff DR, Wohlheiter K, DiClemente C, Goldberg R, Kreyenbuhl J, et al. Correlates of severity of smoking among persons with severe mental illness. Am J Addict. 2007;16(2):101-110. doi:10.1080/10550490601184415. DOI: https://doi.org/10.1080/10550490601184415
Šagud M, Vuksan-Ćusa B, Jakšić N, Mihaljević-Peleš A, Rojnić Kuzman M, Pivac N. Smoking in Schizophrenia: an Updated Review. Psychiatr Danub. 2018;30(Suppl 4):216-223. PMID: 29864763
Mitchell AJ, Vancampfort D, De Hert M, Stubbs B. Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis. Gen Hosp Psychiatry. 2015;37(1):14-23. doi:10.1016/j.genhosppsych.2014.11.006. DOI: https://doi.org/10.1016/j.genhosppsych.2014.11.006
Peckham E, Bradshaw TJ, Brabyn S, Knowles S, Gilbody S. Exploring why people with SMI smoke and why they may want to quit: baseline data from the SCIMITAR RCT. J Psychiatr Ment Health Nurs. 2016;23(5):282-289. doi:10.1111/jpm.12241. DOI: https://doi.org/10.1111/jpm.12241
Gilbody S, Peckham E, Bailey D, Arundel C, Heron P, Crosland S, et al. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial. Lancet Psychiatry. 2019;6(5):379-390. doi:10.1016/S2215-0366(19)30047-1. DOI: https://doi.org/10.1016/S2215-0366(19)30047-1
Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, et al. Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial. J Clin Psychopharmacol. 2019;39(2):108-116. doi:10.1097/JCP.0000000000001015. DOI: https://doi.org/10.1097/JCP.0000000000001015
Ahmed S, Virani S, Kotapati VP, Bachu R, Adnan M, Khan AM, et al. Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis. Front Psychiatry. 2018 Sep 19;9:428. doi: 10.3389/fpsyt.2018.00428. DOI: https://doi.org/10.3389/fpsyt.2018.00428
Gartner C, Hall W. Tobacco harm reduction in people with serious mental illnesses. Lancet Psychiatry. 2015 Jun;2(6):485-7. doi: 10.1016/S2215-0366(15)00238-2. DOI: https://doi.org/10.1016/S2215-0366(15)00238-2
